George Carlone
Overview
Explore the profile of George Carlone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sow S, Okoko B, Diallo A, Viviani S, Borrow R, Carlone G, et al.
N Engl J Med
. 2011 Jun;
364(24):2293-304.
PMID: 21675889
Background: Group A meningococci are the source of major epidemics of meningitis in Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed. Methods: We conducted two studies in...
12.
Williamson Y, Moura H, Schieltz D, Rees J, Woolfitt A, Pirkle J, et al.
J Biomed Biotechnol
. 2010 May;
2010:942365.
PMID: 20508854
Bordetella pertussis (Bp) is the causative agent of pertussis, a vaccine preventable disease occurring primarily in children. In recent years, there has been increased reporting of pertussis. Current pertussis vaccines...
13.
Benson R, Tondella M, Bhatnagar J, Carvalho M, Sampson J, Talkington D, et al.
J Clin Microbiol
. 2008 Apr;
46(6):2074-7.
PMID: 18400916
The ResPlex I assay (Qiagen) was designed to amplify and detect DNA of six bacterial respiratory pathogens. This assay was compared with real-time PCR assays based upon the same target...
14.
Carvalho M, Tondella M, McCaustland K, Weidlich L, McGee L, Mayer L, et al.
J Clin Microbiol
. 2007 Jun;
45(8):2460-6.
PMID: 17537936
The accurate diagnosis of pneumococcal disease has frequently been hampered not only by the difficulties in obtaining isolates of the organism from patient specimens but also by the misidentification of...
15.
Kshirsagar N, Mur N, Thatte U, Gogtay N, Viviani S, Preziosi M, et al.
Vaccine
. 2007 May;
25 Suppl 1:A101-7.
PMID: 17532101
We performed a double-blind, randomized, controlled phase I study to assess safety, immunogenicity, and antibody persistence of the new meningococcal group A conjugate vaccine (PsA-TT) in healthy volunteers aged 18-35...
16.
Romero-Steiner S, Frasch C, Carlone G, Fleck R, Goldblatt D, Nahm M
Clin Vaccine Immunol
. 2006 Feb;
13(2):165-9.
PMID: 16467321
No abstract available.
17.
Jackson L, Neuzil K, Whitney C, Starkovich P, Dunstan M, Yu O, et al.
Vaccine
. 2005 May;
23(28):3697-703.
PMID: 15882530
In a phase I/II dose escalation study, varying volumes (0.1 ml, 0.5 ml, 1.0 ml and 2.0 ml) of 7-valent pneumococcal conjugate vaccine (PCV) (Prevnar or 0.5 ml of 23-valent...
18.
Wernette C, Frasch C, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al.
Clin Diagn Lab Immunol
. 2003 Jul;
10(4):514-9.
PMID: 12853378
No abstract available.
19.
Jodar L, Butler J, Carlone G, Dagan R, Goldblatt D, Kayhty H, et al.
Vaccine
. 2003 Jun;
21(23):3265-72.
PMID: 12804857
The World Health Organization (WHO) is undertaking a series of consultations on serological criteria for the evaluation and licensure of new formulations/combinations or different vaccination schedules of pneumococcal conjugate vaccines....